alzheimer-s

Documents about alzheimer-s

• Cognition in Non-Demented Elderly With a Family History of Alzheimer's Disease#433098DigitalCommons@USU
• Physical activity and Alzheimer’s disease: a call for evidence incorporation#126826HAL (France)
• Astrocytes, via RTP801, contribute to cognitive decline by disrupting GABAergic-regulated connectivity and driving neuroinflammation in an Alzheimer's disease mouse model#184965Dipòsit Digital de la Universitat de Barcelona
• Identification de facteurs de risque génétique liés au sexe pour la maladie d'Alzheimer#14158HAL (France)
• Situación actual de los indicadores de mortalidad por Alzheimer en Castilla y León#438757Gestión del Repositorio Documental de la Universidad de Salamanca
• Amyloid-related imaging abnormalities (ARIA) in anti-amyloid therapies for Alzheimer's disease: An update from the Alzheimer's Association ARIA workgroup.#125278NCBI PubMed Central
• Translational Feasibility of Curcumin for Treatment of Alzheimer’s Disease: A Critical Appraisal of Clinical Challenges#231310Europe PMC
• Influence of Speech Disfluencies and Prompt Optimization in LLM-Based Alzheimer's Disease Classification#246121DigitalCommons@Kennesaw State University
• Glial Cells in Behavioral and Psychological Symptoms of Alzheimer's Disease#246391Europe PMC
• Translational Feasibility of Curcumin for Treatment of Alzheimer's Disease: A Critical Appraisal of Clinical Challenges#246393Europe PMC
• Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer’s disease with hydromethylthionine mesylate using external control data✰✰✰#123242Europe PMC
• Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control data#125809Europe PMC
• Alzheimer's disease in patients prescribed statins: A real-world data analysis of U.S. patient health records#5615Europe PMC
• Mild cognitive impairment-to-Alzheimer's dementia progression risk: the contribution of the Interceptor project#5492Europe PMC
• Olfactory decline tracks central-to-peripheral spread of tau pathology in Alzheimer's disease#120130Europe PMC
• Decisionmaking at the End of Life: Patients with Alzheimer's or Other Dementias#167574Digital Commons @ University of Georgia School of Law
• Public Policy Implications of Liability Regimes for Injuries Caused by Persons with Alzheimer's Disease#167575Digital Commons @ University of Georgia School of Law
• AN INVESTIGATION INTO THE NEUROPROTECTIVE POTENTIAL OF ERGOTHIONEINE IN THE AMYLOID HYPOTHESIS OF ALZHEIMER’S DISEASE#254779ScholarBank@NUS
• Provider and patient perspectives on the diagnosis and treatment of Alzheimer's disease: A global perspective from the Global Alzheimer's Leadership Series (GoALS).#284876NCBI PubMed Central
• Quantitative susceptibility mapping of the brain is associated with inflammatory changes in Alzheimer's disease related areas#333047Europe PMC
• Candesartan's Effects on Alzheimer's Disease And Related Biomarkers#435804ClinicalTrials.gov
• Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associated with increased risk of clinical progression in early Alzheimer's disease#182053Europe PMC
• Serum amino acid levels are associated with brain hypometabolism in patients across the Alzheimer's disease continuum#5363Europe PMC
• Heterogeneous patterns of cognitive decline in Alzheimer's disease across three domains of cognition#144950HAL (France)
• Screening for Alzheimer's disease in the community using an AI-driven screening platform: design of the PREDICTOM study#182054Europe PMC
• Naphthyl-functionalized acetamide derivatives: Promising agents for cholinesterase inhibition and antioxidant therapy in Alzheimer's disease#197436Repositorio UNAB
• A computational framework to predict the spreading of Alzheimer’s disease#248588Spiral
• Dexmedetomidine Exerts Multi-Level Effects to Ameliorate Alzheimer’s Disease Pathology in the Adult Zebrafish Brain#256625İzmir Yüksek Teknoloji Enstitüsü
• An automated plasma‐based proteotyping immunoassay for APOE ε4 zygosity classification in Alzheimer's disease#274386HAL (France)
• Centralized Review of Alzheimer’s Disease and Related Dementias Biomedical Repositories and Computational Methods#314719Europe PMC
• Blood serum from individuals with Alzheimer’s disease alters microglial phagocytosis in vitro#353989HAL (France)
• Low Sensitivity of Neuropsychological Scales Hinder Detection of Potential Benefit of Treatments in Alzheimer's Disease: A Position Paper#5557Europe PMC
• Alzheimer’s Disease Brain Phenotypes are Age-dependent#5466Europe PMC
• Metrifonate for Alzheimer's disease.#461496NCBI PubMed Central
• Benchmarking speech biomarkers of Alzheimer's against cognitive and neural measures#120129Europe PMC
• Integrating the physical environment into Alzheimer's disease and Alzheimer's disease related dementias research: A Gateway Exposome Coordinating Center (GECC) agenda on gaps and priorities.#125276NCBI PubMed Central
• (Alzheimer's) dementia in adults with Down syndrome in Germany: Administrative prevalence based on a claims data analysis#333045Europe PMC
• New Alzheimer’s Disease Diagnostics and Psychological Clinical Perspectives#397098OSF
• The HTT gene influences plasma neurofilament light chain and brain metabolism in prodromal Alzheimer's disease#436342IRIS
• Synthesis, molecular docking, molecular dynamics and DFT studies of new thiazole derivatives as dual cholinesterase inhibitors against alzheimer’s disease#450228Recep Tayyip Erdoğan University Institutional Repository
• Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results#184992Dipòsit Digital de la Universitat de Barcelona
• Cardiovascular risk and hippocampal-cognitive coupling in Alzheimer's disease#332446bioRxiv / medRxiv
• Multiracial participants in Alzheimer's research: scoping review and recommendations.#338352NCBI PubMed Central
• Engineering nanobodies for drug delivery systems in Alzheimer's disease.#9730PubMed
• Brain Blood Flow and Sugar Transport in Alzheimer's Disease With and Without Diabetes - A Pilot Imaging Study#126052ClinicalTrials.gov
• Psychopathologie de la maladie d'Alzheimer : une approche clinique de la mémoire démentielle#235293HAL (France)
• Overcoming the blood‒brain barrier: nanomedicine strategies for targeted delivery and multimodal therapy in Alzheimer's disease#4528Europe PMC
• Signaling cascades shape functional subpopulations of cortical astrocytes in male wild-type mice and APP/PS1dE9 Alzheimer’s disease model#14159HAL (France)
• Divergent patterns of cognitive decline in preclinical Alzheimer's disease: Implications for secondary prevention trials#125782Europe PMC
• Neuroimaging in dementia and Alzheimer's disease: Current protocols and practice in the Republic of Ireland#186496Research Repository UCD